Translational Development Acquisition Corp. (NASDAQ:TDACU) Sees Large Growth in Short Interest

Translational Development Acquisition Corp. (NASDAQ:TDACU) was the recipient of a large increase in short interest in May. As of May 29th, there was short interest totaling 96 shares, an increase of ? from the May 14th total of 0 shares. Based on an average trading volume of 2,588 shares, the short-interest ratio is presently 0.0 days.

Translational Development Acquisition Stock Performance

Shares of Translational Development Acquisition stock traded up $0.15 during midday trading on Monday, hitting $11.65. The company had a trading volume of 1,702 shares, compared to its average volume of 3,896. The company has a fifty day simple moving average of $11.19 and a 200 day simple moving average of $10.73. Translational Development Acquisition has a 12-month low of $10.71 and a 12-month high of $17.29.

About Translational Development Acquisition

Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.

In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.

Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.